Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
7.10
+0.34 (5.03%)
Feb 18, 2026, 4:00 PM EST - Market closed
Cybin Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
355.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 686.88K | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionHELP News
- 1 day ago - Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder - GlobeNewsWire
- 5 days ago - HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 7 weeks ago - Cybin Initiates At-The-Market Equity Program of up to US$100 Million - Business Wire
- 2 months ago - Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq - Business Wire
- 3 months ago - Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - Business Wire
- 3 months ago - Cybin to Participate in the Jefferies Global Healthcare Conference in London - Business Wire
- 3 months ago - Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025 - Business Wire